STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
344
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $3.1M priced
What the filings say about RRX
Insiders, 180 days
-$8.3M net sold
5 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-09-23
Planned sales (Form 144), 90 days
$30.0K
1 notice
Regal Rexnord insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, REGAL REXNORD CORP insiders sold a net $8.3M of stock across 48 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Feb 25, 2026.
The trade is 5.2% of the 3,274 shares held after it.
No other insider sold within 30 days.
344 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: SVP, Corp. Controller and CAO* Scarpelli Alexander P sold about $30.0K of RRX on Aug 10, 2026; 344 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Feb 25, 2026.
The trade is 23.2% of the 27,964 shares held after it.
3 other insiders sold within 30 days.
344 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP and CFO* Rehard Robert sold about $1.3M of RRX on May 22, 2026; 3 other insiders sold within 30 days and 344 funds added in the latest 13F quarter.
3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Feb 9, 2026.
The trade is 55.9% of the 16,806 shares held after it.
3 other insiders sold within 30 days.
344 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP and Pres. IPS* Morton Jerrald R sold about $2.0M of RRX on May 14, 2026; 3 other insiders sold within 30 days and 344 funds added in the latest 13F quarter.
15 earlier Form 4 trades (code P or S) here by this insider (15 sales), the last on Feb 9, 2026.
The trade is 0.5% of the 56,748 shares held after it.
3 other insiders sold within 30 days.
344 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Pinkham Louis V. sold about $64.7K of RRX on May 11, 2026; 3 other insiders sold within 30 days and 344 funds added in the latest 13F quarter.
15 earlier Form 4 trades (code P or S) here by this insider (15 sales), the last on Feb 9, 2026.
The trade is 3.3% of the 57,047 shares held after it.
3 other insiders sold within 30 days.
344 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Pinkham Louis V. sold about $409.3K of RRX on May 11, 2026; 3 other insiders sold within 30 days and 344 funds added in the latest 13F quarter.
48 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
RRX planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Scarpelli Alexander P
Filed 2026-08-10
$30.0K
RRX mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
CRM ALL CAP VALUE FUND
$758.1K position · as of 2026-07-31
3.8%
DIAMOND HILL SMALL-MID CAP FUND
$23.9M position · as of 2026-06-30
3.8%
CRM MID CAP VALUE FUND
$9.4M position · as of 2026-07-31
3.5%
CRM SMALL/MID CAP VALUE FUND
$6.3M position · as of 2026-07-31
3.5%
Touchstone Funds Group Trust-Touchstone Mid Cap Value Fund
$18.9M position · as of 2026-06-30
3.3%
DIAMOND HILL MID CAP FUND
$2.4M position · as of 2026-06-30
3.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Louis V. Pinkham
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$11.5M
$5.8M
$2.9M
+26%
+91%
2024
$11.9M
$12.2M
$2.9M
+38%
+70%
2023
$11.5M
$13.7M
$2.9M
+30%
+49%
2022
$8.6M
-$1.5M
$2.2M
+4%
+14%
2021
$7.4M
$19.1M
$1.9M
+47%
+28%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $8.3M sold by insiders over 180 days, 344 funds added last quarter, $30.0K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$6.1B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM RRX
FY Dec 2025
$5.9B
FY Dec 2024
$6.0B
FY Dec 2023
$6.3B
FY Dec 2022
$5.2B
FY Jan 2022
$3.8B
Jun 2026
$1.6B
Mar 2026
$1.5B
Dec 2025
$1.5B
Sep 2025
$1.5B
Jun 2025
$1.5B
Mar 2025
$1.4B
Dec 2024
$1.5B
Sep 2024
$1.5B
At each fiscal year end
Single quarter
Net margin, TTM
+5.4%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM RRX
FY Dec 2025
+4.7%
FY Dec 2024
+3.3%
FY Dec 2023
-0.9%
FY Dec 2022
+9.4%
FY Jan 2022
n/a
Jun 2026
+7.5%
Mar 2026
+4.3%
Dec 2025
+4.2%
Sep 2025
+5.3%
Jun 2025
+5.3%
Mar 2025
+4.0%
Dec 2024
+2.8%
Sep 2024
+4.9%
At each fiscal year end
Single quarter
Free cash flow, TTM
$466.3M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM RRX
FY Dec 2025
$893.1M
FY Dec 2024
$499.9M
FY Dec 2023
$596.2M
FY Dec 2022
$352.4M
FY Jan 2022
$303.2M
Jun 2026
$154.2M
Mar 2026
-$2.5M
Dec 2025
$140.6M
Sep 2025
$174.0M
Jun 2025
$493.0M
Mar 2025
$85.5M
Dec 2024
$183.9M
Sep 2024
$125.5M
At each fiscal year end
Single quarter
Debt to equity
0.67x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity RRX
FY Dec 2025
0.70x
FY Dec 2024
0.87x
FY Dec 2023
1.01x
FY Dec 2022
0.32x
FY Jan 2022
0.30x
Jun 2026
0.67x
Mar 2026
0.69x
Dec 2025
0.70x
Sep 2025
0.71x
Jun 2025
0.72x
Mar 2025
0.82x
Dec 2024
0.87x
Sep 2024
0.87x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.12x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt RRX
FY Dec 2025
0.21x
FY Dec 2024
0.11x
FY Dec 2023
0.11x
FY Dec 2022
0.22x
FY Jan 2022
0.19x
Jun 2026
0.12x
Mar 2026
0.19x
Dec 2025
0.21x
Sep 2025
0.22x
Jun 2025
0.20x
Mar 2025
0.12x
Dec 2024
0.11x
Sep 2024
0.11x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+4.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity RRX
FY Dec 2025
+4.3%
FY Dec 2024
+3.1%
FY Dec 2023
-0.9%
FY Dec 2022
+7.7%
FY Jan 2022
n/a
Jun 2026
+4.8%
Mar 2026
+4.3%
Dec 2025
+4.3%
Sep 2025
+3.9%
Jun 2025
+3.8%
Mar 2025
+3.7%
Dec 2024
+3.1%
Sep 2024
+3.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets RRX
FY Dec 2025
+2.0%
FY Dec 2024
+1.3%
FY Dec 2023
-0.4%
FY Dec 2022
+4.7%
FY Jan 2022
n/a
Jun 2026
+2.3%
Mar 2026
+2.1%
Dec 2025
+2.0%
Sep 2025
+1.8%
Jun 2025
+1.8%
Mar 2025
+1.6%
Dec 2024
+1.3%
Sep 2024
+1.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+5.2%
operating income after a 18.5% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital RRX
FY Dec 2025
+5.0%
FY Dec 2024
+4.5%
FY Dec 2023
n/a
FY Dec 2022
+7.2%
FY Jan 2022
n/a
Jun 2026
+5.2%
Mar 2026
+5.0%
Dec 2025
+5.0%
Sep 2025
+5.0%
Jun 2025
+5.0%
Mar 2025
+4.7%
Dec 2024
+4.5%
Sep 2024
+4.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+5.6%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed RRX
FY Dec 2025
+5.3%
FY Dec 2024
+4.7%
FY Dec 2023
+3.2%
FY Dec 2022
+7.4%
FY Jan 2022
n/a
Jun 2026
+5.6%
Mar 2026
+5.3%
Dec 2025
+5.3%
Sep 2025
+5.0%
Jun 2025
+5.0%
Mar 2025
+4.9%
Dec 2024
+4.7%
Sep 2024
+5.0%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
31.03x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing RRX
FY Dec 2025
33.41x
FY Dec 2024
52.59x
FY Dec 2023
n/a
FY Dec 2022
16.44x
FY Jan 2022
30.28x
Jun 2026
49.11x
Mar 2026
43.55x
Dec 2025
33.41x
Sep 2025
37.06x
Jun 2025
38.55x
Mar 2025
32.44x
Dec 2024
52.59x
Sep 2024
52.33x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$14.2B
market value at close 2026-10-26 on 2026-07-31 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value RRX
FY Dec 2025
$13.6B
FY Dec 2024
$15.3B
FY Dec 2023
$15.6B
FY Dec 2022
$9.3B
FY Jan 2022
$12.8B
Jun 2026
$20.0B
Mar 2026
$16.8B
Dec 2025
$13.6B
Sep 2025
$13.9B
Jun 2025
$14.2B
Mar 2025
$12.5B
Dec 2024
$15.3B
Sep 2024
$16.2B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+4.7%
TTM free cash flow over market value at close 2026-10-26
FCF yield RRX
FY Dec 2025
+9.6%
FY Dec 2024
+4.9%
FY Dec 2023
+6.1%
FY Dec 2022
+4.4%
FY Jan 2022
+2.6%
Jun 2026
+2.9%
Mar 2026
+6.5%
Dec 2025
+9.6%
Sep 2025
+9.8%
Jun 2025
+9.2%
Mar 2025
+6.9%
Dec 2024
+4.9%
Sep 2024
+4.4%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
1.07x
P/E over trailing EPS growth of 29%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing RRX
FY Dec 2025
0.79x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
0.55x
FY Jan 2022
1.43x
Jun 2026
1.69x
Mar 2026
1.93x
Dec 2025
0.79x
Sep 2025
1.68x
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
RRX ranks highest on institutional and government (76th percentile) and risk and compliance (52nd), and lowest on insider conviction (12th), among Industrials peers.
Profitability
34
Inputs
Return on equity+4.8% · 39 pct, sector of 198
Return on assets+2.3% · 43 pct, sector of 224
Return on invested capital+5.2% · 14 pct, sector of 107
Return on capital employed+5.6% · 41 pct, sector of 195
Financial health
30
Inputs
Debt to equity0.67x · 32 pct, sector of 214
Cash flow to debt0.12x · 28 pct, sector of 173
Growth
26
Inputs
Revenue growth, YoY-1.6% · 26 pct, sector of 254
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
12
Inputs
Net Form 4 buying (codes P and S), 180d-$8.3M · 24 pct, sector of 170
Insider buyers, 180d0 · 0 pct, sector of 172
Institutional and government
76
Inputs
Funds adding, latest quarter344 · 76 pct, sector of 201
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
52
Inputs
Short interest, % of float+6.0% · 34 pct, sector of 269
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 191
New text in Risk Factors, latest 10-K+20.2% · 22 pct, sector of 197
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
RRX filings, in plain words
Are Regal Rexnord insiders buying or selling RRX?
In the 180 days to 2026-10-28, Regal Rexnord insiders were net sellers, a net $8.3M across purchases and sales reported on Form 4, by 5 sellers.
Have members of Congress traded RRX?
Yes, but not in the year to 2026-10-28; the latest on record is a sale by Valerie Hoyle dated 2025-09-23.
Are there planned insider sales of RRX?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $30.0K of stock; the latest, by Scarpelli Alexander P, was filed 2026-08-10.
Read the full summary
In the 180 days to 2026-10-28, Regal Rexnord insiders were net sellers of RRX, a net $8.3M across purchases and sales reported on Form 4 by 5 sellers. None of the 11 insider sales was flagged as made under a Rule 10b5-1 plan. Members of Congress have disclosed trades in RRX, none in the last year; the latest on record is a sale by Valerie Hoyle dated 2025-09-23. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $30.0K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.